An interventional study of Myofascial Release Therapy (MRT) Group and Kinesiotape (KT) Group in Dysmenorrhea Primary, sponsored by Medipol University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2025-08-01.
Sponsored by Medipol University · Not applicable, Interventional, and Supportive care
This study is investigating the effects of myofascial release technique \& kinesiotape in managing dysmenorrhea
Dysmenorrhea is a common gynecological disorder characterized by painful menstruation manifested by severe cramps in the lower abdomen. Recent epidemiological studies indicate a global prevalence of 50-90% among women (10-20% with severe symptoms); in Türkiye, studies show a prevalence of 75-85%.Dysmenorrhea is divided into two types: primary dysmenorrhea (PD) and secondary dysmenorrhea. PD is painful menstruation without any underlying pathological condition. The main goal of dysmenorrhea treatment is to significantly improve the patient's well-being and quality of life (QoL) by effectively relieving pain and relieving symptoms by targeting physiological mechanisms. There are various physiotherapy methods that can be used to reduce this pain, such as transcutaneous electrical nerve stimulation (TENS), cryotherapy, myofascial release therapy (MRT), and kinesiology taping (KT).
This single-blind randomized controlled trial will investigate the acute therapeutic effects of Myofascial Release Technique (MRT) versus Kinesio Taping (KT) in 46 females aged 18-30 years with PD. Participants will be randomised into Group 1 (MRT; n = 23) or Group 2 (KT; n = 23), receiving a single intervention session during their most painful menstrual day
All participants will be asked to fill out 3 forms, namely a sociodemographic questionnaire covering age, height, BMI, age at menarche and duration of menstruation, a Visual Analog Scale (VAS) to assess pain level and a Patient Reported Outcomes Measurement System (PROMIS-29 Profile v2.0) to measure quality of life (QoL) at 3 time points (pre-intervention, 8 hours after intervention ,and 3-5 weeks post intervention (at the first menstrual cycle after intervention).
Statistical analyses will be conducted by using SPSS 27.0 (IBM Corp.), with a priori power analysis confirming 95% power (α = 0.05; G*Power v3.1.9.7). Data normality will be verified via the Shapiro-Wilk test. Independent Samples t-tests will compare interventional effects between groups, while one-way ANOVA (with LSD post-hoc tests) will analyze multi-point QoL changes. Paired Samples t-tests will evaluate within-group temporal changes (pre vs. post-intervention).
2,219 studies on the registry are indexed under Pain; 917 are open to participants now.
This study's planned enrollment of 46 is below the median of 70 across 1,904 interventional studies indexed under Pain.
Browse Pain studies →Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in this arm will receive Kinesio Taping applied to the lower abdomen and lumbar region using a 3-Tape Sensory Modulation Technique to modulate pain and fascial tension.
Other: Kinesiotape (KT) Group
Participants in this arm will receive a single session of myofascial release technique (MRT) which is a type of massage that will target anterolateral abdominal wall, including Camper and Scarpa fascia, as well as the deeper layers, including transversals fascia and the thoracolumbar fascia to release the fascial restrictions.
Other: Myofascial Release Therapy (MRT) Group
Myofascial Release Therapy (MRT) involves hands-on palpation to detect fascial restrictions, followed by 60-90 seconds of sustained pressure to release tension. In the supine position, the target areas include the superficial fascia, transversalis fascia, and extraperitoneal fascia, while in the prone position, the focus shifts to the thoracolumbar fascia and the erector spinae complex. This technique aims to restore mobility and reduce restrictions within the fascial system. Frequency: Each patient will recieve a single session at their most painful day from this intervention.
Kinesio Taping (KT) Intervention Description: Participants will receive a standardized 3-tape sensory modulation technique using Kinesiotape, applied to the abdomen and sacrum to target fascial tension and visceral pain in primary dysmenorrhea. Procedure: Abdominal Application (Two Tapes, 0% Stretch): Horizontal Tape: Placed between the iliac crests (lower abdomen) to reduce fascial tension. Vertical Tape: Applied from the navel to the pubic symphysis to modulate visceral pain signaling. Sacral Application (One Tape, 15-25% Stretch): Horizontal Tape: Anchored across the S2-S4 vertebrae (at PSIS level) to activate the pain-gating mechanism via cutaneous-visceral reflexes. Frequency/Duration: Each participant will receive a single session at their most painful day from this intervention
Visual Analogue Scale (VAS)
It is a pain assessment tool featuring a 10-cm line marked "No pain" (0 cm) and "Worst pain imaginable" (10 cm). Patients indicate their pain level by marking the line, with scores measured in cm (0-10) and categorised as mild (0-3), moderate (4-6), or severe (7-10)
Time frame: Before the interventions, after 8 hours from the interventions, & 3-5 weeks post-intervention (first menstrual cycle after interventions)
Patient-Reported Outcomes Measurement Information System (PROMIS-29 Profile v2.0)
It is a quality of life scale that questions physical function, anxiety, depression, fatigue, sleep disturbance, social roles and activities, pain interference and severity under its subheadings
Time frame: Before the interventions, after 8 hours from the interventions, & 3-5 weeks post-intervention (first menstrual cycle after interventions)
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medipol University